Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Wound Repair Regen ; 17(1): 99-107, 2009.
Artículo en Inglés | MEDLINE | ID: mdl-19152656

RESUMEN

During wound healing, the wound site is rich in oxidants, such as hydrogen peroxide, mostly contributed by neutrophils and macrophages. Ascorbic acid and tannins of low molecular weight, namely emblicanin A (2,3-di-O-galloyl-4,6-(S)-hexahydroxydiphenoyl-2-keto-glucono-delta-lactone) and emblicanin B (2,3,4,6-bis-(S)-hexahydroxydiphenoyl-2-keto-glucono-delta-lactone) present in Emblica officinalis (emblica), have been shown to exhibit a very strong antioxidant action. We proposed that addition of these antioxidants to the wound microenvironment would support the repair process. The present investigation was undertaken to determine the efficacy of emblica on dermal wound healing in vivo. Full-thickness excision wounds were made on the back of the rat and topical application of emblica accelerated wound contraction and closure. Emblica increased cellular proliferation and cross-linking of collagen at the wound site, as evidenced by an increase in the activity of extracellular signal-regulated kinase 1/2, along with an increase in DNA, type III collagen, acid-soluble collagen, aldehyde content, shrinkage temperature and tensile strength. Higher levels of tissue ascorbic acid, alpha-tocopherol, reduced glutathione, superoxide dismutase, catalase, and glutathione peroxidase support the fact that emblica application promotes antioxidant activity at the wound site. In summary, this study provides firm evidence to support that topical application of emblica represents a feasible and productive approach to support dermal wound healing.


Asunto(s)
Colágeno/metabolismo , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Phyllanthus emblica/metabolismo , Fitoterapia/métodos , Preparaciones de Plantas/farmacología , Cicatrización de Heridas/efectos de los fármacos , Cicatrización de Heridas/fisiología , Análisis de Varianza , Animales , Western Blotting , Masculino , Ratas , Ratas Wistar , Resistencia a la Tracción , Regulación hacia Arriba
2.
Mol Cell Biochem ; 268(1-2): 149-58, 2005 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-15724448

RESUMEN

This study attempted to probe the role of complement activation in promoting acute myocardial infarction (AMI) induced by coronary artery ligation (CAL) in rats. The surgical technique used in this study significantly reduced early mortality (95% survival rate) and also reduced the variation in infarct size (33+/-1.87%) at 32 h after surgery. Time course studies on the initiation of AMI at various time points were carried out using physiological, biochemical, histopathological and electron microscopical techniques. Serum markers and activities of lysosomal hydrolases were found to be significantly elevated at the 8th hour post ligation. Histological studies showed polymorphonuclear cells emigration and total coagulation necrosis. Transmission electron micrograph exhibited mild distortion of muscle fibres and mitochondrial rupture with disrupted cristae. Immunoblotting studies confirmed the presence of alpha2-macroglobulin which supported the inflammatory response at 8th h of post ligation. The initiation of the complement (C) activation was observed by the increase in the level of the soluble form of the membrane attack complex (sC5b-9) in serum and left ventricle. Immunoexpression studies confirmed the initiation of the terminal C activation as shown by the expression of C5, C6, C7, C8, C9 and sC5b-9 complex at the 8th h of AMI. This study conclusively demonstrated that initiation of the C activation was observed to be significant at the 8th h of AMI induced by CAL in rats.


Asunto(s)
Activación de Complemento , Proteínas del Sistema Complemento/análisis , Ventrículos Cardíacos/metabolismo , Infarto del Miocardio/sangre , Miocardio/metabolismo , Animales , Proteínas del Sistema Complemento/metabolismo , Ventrículos Cardíacos/patología , Masculino , Infarto del Miocardio/patología , Miocardio/patología , Ratas , Ratas Wistar , Factores de Tiempo , alfa-Macroglobulinas/análisis , alfa-Macroglobulinas/metabolismo
3.
Int J Biochem Cell Biol ; 37(3): 566-73, 2005 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-15618014

RESUMEN

Wound healing occurs as a fundamental response to tissue injury. Several natural products have been shown to accelerate the healing process. The present investigation was undertaken to determine the efficacy of topical administration of an alcoholic bark extract of Butea monosperma (B. monosperma) on cutaneous wound healing in rats. Full-thickness excision wounds were made on the back of rat and B. monosperma extract was administered topically. The granulation tissue formed on days 4, 8, 12 and 16 (post-wound) was used to estimate total collagen, hexosamine, protein, DNA and uronic acid. The extract increased cellular proliferation and collagen synthesis at the wound site, as evidenced by increase in DNA, total protein and total collagen content of granulation tissues. The extract treated wounds were found to heal much faster as indicated by improved rates of epithelialization and wound contraction, also confirmed by histopathological examinations. Also, the tensile strength of drug-treated wounds was increased significantly. In addition, we show that B. monosperma possesses antioxidant properties, by its ability to reduce lipid peroxidation. The results clearly substantiate the beneficial effects of the topical application of B. monosperma in the acceleration of wound healing.


Asunto(s)
Butea , Extractos Vegetales/farmacología , Piel/lesiones , Cicatrización de Heridas/efectos de los fármacos , Administración Tópica , Animales , Colágeno/efectos de los fármacos , ADN/efectos de los fármacos , Evaluación Preclínica de Medicamentos , Tejido de Granulación/química , Tejido de Granulación/metabolismo , Hexosaminas/metabolismo , Masculino , Corteza de la Planta/química , Plantas Medicinales/química , Proteínas/efectos de los fármacos , Ratas , Ratas Wistar , Piel/metabolismo , Piel/patología , Resistencia a la Tracción , Ácidos Urónicos/metabolismo
4.
Life Sci ; 75(15): 1887-96, 2004 Aug 27.
Artículo en Inglés | MEDLINE | ID: mdl-15302232

RESUMEN

Several anesthetics are known to cause respiratory and cardiovascular depression in humans and animals; but, these diverse effects have not been extensively investigated in laboratory rodents. The objective of this study is to choose a suitable anesthetic combination for use in surgical models eg. coronary artery ligation in rats. Male Wistar rats were anesthetized with three different drugs viz. diazepam-ketamine (DK) (2.5 mg/Kg, intraperitoneally (i.p); 50 mg/Kg, i.p), xylazine-ketamine (XK) (5 mg/Kg i.p; 50 mg/Kg i.p) and thiopentone (T) (40 mg/Kg i.p) and the respiratory and cardiovascular functions were assessed after coronary artery ligation. Heart rate (HR), mean arterial pressure (MAP), partial pressure of carbon dioxide (PaCO2), partial pressure of oxygen (PaO2), oxygen saturation percentage (O2 sat (%)), arterial blood pH and rectal body temperature were studied in detail. During the anesthetic regime, HR was lower till 60 min in XK and T ligated group (333 +/- 6; 304 +/- 8 beats/min) and it was near normalcy in the case of DK ligated group (394 +/- 6 beats/min). Significant respiratory depression was particularly reflected in the T ligated group with an increase in PaCO2 at 30 min (40.32 +/- 2.64 mmHg), which decreased to 38.2 +/- 2.23 mmHg at 60 min. Throughout the investigation, DK showed the least overall effects compared to XK and T on respiratory functions. Thus, DK could be considered to be a suitable anesthetic for use in a surgical model such as coronary artery ligation in albino rats.


Asunto(s)
Agonistas alfa-Adrenérgicos/farmacología , Anestesia Intravenosa , Anestésicos Disociativos/farmacología , Anestésicos Intravenosos/farmacología , Diazepam/farmacología , Corazón/efectos de los fármacos , Ketamina/farmacología , Mecánica Respiratoria/efectos de los fármacos , Tiopental/farmacología , Xilazina/farmacología , Animales , Análisis de los Gases de la Sangre , Presión Sanguínea/efectos de los fármacos , Temperatura Corporal/efectos de los fármacos , Vasos Coronarios/cirugía , Combinación de Medicamentos , Electrocardiografía/efectos de los fármacos , Frecuencia Cardíaca/efectos de los fármacos , Masculino , Ratas , Ratas Wistar
5.
Int J Biochem Cell Biol ; 36(10): 1967-80, 2004 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-15203111

RESUMEN

This study was designed to investigate the protective effect of curcumin (CUR) against isoprenaline induced myocardial ischaemia in rat myocardium. The effect of single oral dose of curcumin (15 mg kg(-1)), administered 30 min before and/or after the onset of ischaemia, was investigated by assessing oxidative stress related biochemical parameters in rat myocardium. Curcumin pre and post-treatment (PPT) was shown to decrease the levels of xanthine oxidase, superoxide anion, lipid peroxides (LPs) and myeloperoxidase while the levels of superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx), glutathione-S-transferase (GST) activities were significantly increased after curcumin PPT. Histopathological and transmission electron microscopical studies also confirmed the severe myocardial damage occurring as a consequence of isoprenaline induced ischaemia and they also showed the significant improvement effected by curcumin PPT. These findings provided evidence that curcumin was found to protect rat myocardium against ischaemic insult and the protective effect could be attributed to its antioxidant properties as well as its inhibitory effects on xanthine dehydrogenase/xanthine oxidase (XD/XO) conversion and resultant superoxide anion production.


Asunto(s)
Curcumina/farmacología , Radicales Libres/metabolismo , Isquemia Miocárdica/metabolismo , Animales , Pruebas de Coagulación Sanguínea , Modelos Animales de Enfermedad , Femenino , Hemodinámica/efectos de los fármacos , Peróxidos Lipídicos/metabolismo , Estructura Molecular , Isquemia Miocárdica/patología , Isquemia Miocárdica/fisiopatología , Estrés Oxidativo/efectos de los fármacos , Extractos Vegetales/farmacología , Agregación Plaquetaria/efectos de los fármacos , Ratas , Ratas Wistar , Superóxidos/metabolismo , Trombina/farmacología
6.
Mol Cell Biochem ; 267(1-2): 47-58, 2004 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-15663185

RESUMEN

In vivo models of myocardial infarction induced by coronary artery ligation (CAL) in rats usually suffer from high early mortality and a low rate of induction. This study investigated the time course initiation of chronic myocardial infarction (CMI) in albino rats and the possibility of reducing early mortality rate due to myocardial infarction by modification of the surgical technique. CAL was carried out by passing the suture through the epicardial layer around the midway of the left anterior descending coronary artery including a small area of the myocardium to avoid mechanical damage to the heart geometry. In addition, the role of endothelin-1 (ET-1) in rat heart with congestive heart failure was critically assessed. Time course initiation experiments were designed by sacrificing the animals at different time intervals and by carrying out physiological, biochemical, histopathological, electron microscopical and immunohistochemical studies. Specific markers of myocardial injury, viz. cardiac troponin-T (cTnT), high sensitivity C-reactive protein, lactate dehydrogenase and fibrinogen were measured at different time points. Serum marker enzymes and activities of lysosomal hydrolases were found to be elevated on the eighth day post-ligation. Histopathological studies demonstrated focal areas showing fibrovascular tissue containing fibroblasts, collagenous ground substance and numerous small capillaries replacing cardiac muscle fibers. Transmission electron micrographs exhibited mitochondrial changes of well-developed irreversible cardiac injury, viz. swelling, disorganization of cristae, appearance of mitochondrial amorphous matrix densities, significant distortion of muscle fibers and distinct disruption of the intercalated discs. Immunoblotting studies confirmed the presence of alpha 2-macroglobulin which supported the inflammatory response. The severity of the CMI was inferred by the measurement of the level of ET-1 in plasma and left ventricle which was significantly higher in the CMI rats than in the sham-operated rats. Immunohistochemical studies at different time intervals showed that there was a significant immunoexpression of ET-1 on the eighth day post-ligation. This study conclusively showed that ligation of left anterior descending artery minimized mortality and ET-1 was expressed during CMI.


Asunto(s)
Modelos Animales de Enfermedad , Infarto del Miocardio/metabolismo , Infarto del Miocardio/fisiopatología , Animales , Biomarcadores , Presión Sanguínea , Western Blotting , Proteína C-Reactiva/metabolismo , Electrocardiografía , Electroforesis en Gel de Poliacrilamida , Endotelina-1/biosíntesis , Endotelina-1/sangre , Insuficiencia Cardíaca , Hidrolasas , Inmunohistoquímica , Cinética , L-Lactato Deshidrogenasa/sangre , Ligadura , Lisosomas/enzimología , Masculino , Mitocondrias Cardíacas/enzimología , Mitocondrias Cardíacas/ultraestructura , Infarto del Miocardio/sangre , Infarto del Miocardio/patología , Ratas , Ratas Wistar , Índice de Severidad de la Enfermedad , Troponina T/sangre , alfa-Macroglobulinas/metabolismo
7.
Pharmacology ; 65(2): 103-9, 2002 May.
Artículo en Inglés | MEDLINE | ID: mdl-11937781

RESUMEN

A novel tetrapeptide derivative Boc-Lys(Boc)-Arg-Asp-Ser(tbu)-OtBu (PEP1261) has been tested in vivo in isoproterenol (ISO) hydrochloride (HCl)-induced myocardial necrosis in rats. ISO x HCl induces myocardial necrosis in rats which is accompanied by the distinct increase in heart weight, marked electrocardiographic changes, increase in the levels of serum marker enzymes and lipid peroxides and decrease in the levels of antioxidants. PEP1261 (5 mg/kg body weight i.p.) pre- and post-treatment effectively decreases serum marker enzyme levels, while the electrocardiographic changes get restored towards normalcy. PEP1261 also inhibits the action of the free radicals toxicity by increasing the levels of antioxidants and histological studies confirm the above findings. This study shows that PEP1261 could serve as an excellent cardioprotective agent possessing membrane-stabilizing action.


Asunto(s)
Antioxidantes/farmacología , Isoproterenol/farmacología , Miocardio/patología , Oligopéptidos/farmacología , Animales , Electrocardiografía , Femenino , Corazón/efectos de los fármacos , Corazón/fisiopatología , Peróxidos Lipídicos/sangre , Peróxidos Lipídicos/metabolismo , Miocardio/metabolismo , Necrosis , Oligopéptidos/síntesis química , Ratas , Ratas Wistar
8.
Mol Cell Biochem ; 229(1-2): 9-17, 2002 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11936851

RESUMEN

A tetrapeptide derivative PEP1261 [Boc-Lys-(Boc)-Arg-Asp-Ser-(tBu)-OtBu], corresponding to residues 39-42 of human lactoferrin, was tested for its antiinflammatory action in adjuvant induced arthritis in rats. Administration of heat killed Mycobacterium tuberculosis (500 microg/0.1 ml of paraffin oil) intradermally into the foot pad of right hind paw resulted in an increased paw volume and an increase in the levels of reactive oxygen species and beta-glucuronidase as well as a decrease in the antioxidants levels. PEP1261, at an effective dose of 10 mg/kg body wt., exhibited a significant antiarthritic activity as evidenced by lowering of paw volume and inhibited the free radicals toxicity by increasing the antioxidants levels. This peptide derivative was also shown to have a membrane stabilizing action by significantly decreasing the total and free activity of beta-glucuronidase and inhibiting the rate of release of the enzyme from lysosomal rich fraction. Histopathological studies confirmed the above results by showing a decrease in mononuclear cell infiltration, hypertrophy, hyperplasia and pannus formation after PEP1261 treatment in arthritic rats.


Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Antioxidantes/uso terapéutico , Artritis Experimental/tratamiento farmacológico , Lactoferrina/uso terapéutico , Fragmentos de Péptidos/uso terapéutico , Animales , Antiinflamatorios no Esteroideos/metabolismo , Antioxidantes/metabolismo , Huesos/metabolismo , Diclofenaco/metabolismo , Diclofenaco/farmacología , Glucuronidasa/metabolismo , Lisosomas/metabolismo , Masculino , Ratas , Ratas Wistar , Especies Reactivas de Oxígeno/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA